Mario Castro

Active 1991–2025

238
Papers
38,766
Citations
98
h-index
213
i10-index

Citations

Citations per year for Mario Castro1993: 1 citations1995: 1 citations1997: 5 citations1998: 10 citations1999: 25 citations2000: 27 citations2001: 26 citations2002: 34 citations2003: 29 citations2004: 30 citations2005: 28 citations2006: 32 citations2007: 41 citations2008: 74 citations2009: 123 citations2010: 114 citations2011: 195 citations2012: 304 citations2013: 288 citations2014: 323 citations2015: 336 citations2016: 361 citations2017: 457 citations2018: 411 citations2019: 1,660 citations2020: 1,867 citations2021: 1,821 citations2022: 1,549 citations2023: 1,038 citations2024: 1,559 citations2025: 904 citations2026: 16 citations1994: no citations, so this year is not shown1996: no citations, so this year is not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 3,466 citing papers, 23% of this breakdownUnited Kingdom: 1,417 citing papers, 9.4% of this breakdownChina: 819 citing papers, 5.4% of this breakdownItaly: 775 citing papers, 5.2% of this breakdownCanada: 649 citing papers, 4.3% of this breakdownGermany: 634 citing papers, 4.2% of this breakdownFrance: 581 citing papers, 3.9% of this breakdownAustralia: 558 citing papers, 3.7% of this breakdownNetherlands: 503 citing papers, 3.3% of this breakdownJapan: 473 citing papers, 3.2% of this breakdownSpain: 441 citing papers, 2.9% of this breakdownSweden: 377 citing papers, 2.5% of this breakdown
0%23%Other 29%

Fields

  • Medicine72.6%
  • Biochemistry, Genetics and Molecular Biology9.1%
  • Immunology and Microbiology8.4%
  • Neuroscience1.8%
  • Engineering1.1%
  • Environmental Science1.1%
  • Other5.9%

Topics

  • Asthma and respiratory diseases19.9%
  • Respiratory and Cough-Related Research5.1%
  • IL-33, ST2, and ILC Pathways4.7%
  • Chronic Obstructive Pulmonary Disease (COPD) Research4.6%
  • Allergic Rhinitis and Sensitization3.7%
  • Delphi Technique in Research3.2%
  • Other58.8%

Coauthors

All papers

Open in search
  1. International ERS/ATS guidelines on definition, evaluation and treatment of severe asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - European Respiratory Journal 2013 cited by 3,924

  2. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 1,929

  3. Efficacy and Safety of Dupilumab in Glucocorticoid-Dependent Severe Asthma

    Authors: , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2018 cited by 1,162

  4. Mucus plugs in patients with asthma linked to eosinophilia and airflow obstruction

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2018 cited by 598

  5. Reslizumab for inadequately controlled asthma with elevated blood eosinophil counts: results from two multicentre, parallel, double-blind, randomised, placebo-controlled, phase 3 trials

    Authors: , , , , , , , , , - The Lancet Respiratory Medicine 2015 cited by 1,173

  6. Identification of Asthma Phenotypes Using Cluster Analysis in the Severe Asthma Research Program

    Authors: , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2009 cited by 2,124

  7. Management of severe asthma: a European Respiratory Society/American Thoracic Society guideline

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Satoshi Konno, Huahao Shen, Cathy Vitary, Andy Bush - European Respiratory Journal 2019 cited by 614

  8. Role of Biologics in Asthma

    Authors: , , , - American Journal of Respiratory and Critical Care Medicine 2018 cited by 429

  9. Dupilumab efficacy and safety in adults with uncontrolled persistent asthma despite use of medium-to-high-dose inhaled corticosteroids plus a long-acting β2 agonist: a randomised double-blind placebo-controlled pivotal phase 2b dose-ranging trial

    Authors: , , , , , , , , , , , , , , , - The Lancet 2016 cited by 880

  10. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts

    Authors: , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2016 cited by 535

  11. Understanding the key issues in the treatment of uncontrolled persistent asthma with type 2 inflammation

    Authors: , , , , , , - European Respiratory Journal 2021 cited by 160

  12. Extracellular DNA, Neutrophil Extracellular Traps, and Inflammasome Activation in Severe Asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2019 cited by 269

  13. Long-term safety and efficacy of dupilumab in patients with moderate-to-severe asthma (TRAVERSE): an open-label extension study

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Respiratory Medicine 2021 cited by 219

  14. Neutrophil cytoplasts induce T H 17 differentiation and skew inflammation toward neutrophilia in severe asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Science Immunology 2018 cited by 238

  15. Mucus Plugs Persist in Asthma, and Changes in Mucus Plugs Associate with Changes in Airflow over Time

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2022 cited by 141

  16. Features of the bronchial bacterial microbiome associated with atopy, asthma, and responsiveness to inhaled corticosteroid treatment

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2016 cited by 308

  17. Airway microbiota and bronchial hyperresponsiveness in patients with suboptimally controlled asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2010 cited by 696

  18. Inflammatory and Comorbid Features of Patients with Severe Asthma and Frequent Exacerbations

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Ross Myers, Maria Theresa D. Opina, Michael C. Peters, Mark L. Schiebler, Ronald L. Sorkness, W. Gerald Teague, Sally E. Wenzel, Prescott G. Woodruff, David T. Mauger, John V. Fahy, Nizar N. Jarjour - American Journal of Respiratory and Critical Care Medicine 2016 cited by 444

  19. Eosinophils and tissue remodeling: Relevance to airway disease

    Authors: , , , , , , , , , - Journal of Allergy and Clinical Immunology 2023 cited by 109

  20. CCL5 is a potential bridge between type 1 and type 2 inflammation in asthma

    Authors: , , , , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2023 cited by 61

  21. Reslizumab for Poorly Controlled, Eosinophilic Asthma: A Randomized, Placebo-controlled Study

    Authors: , , , , , , , , - American Journal of Respiratory and Critical Care Medicine 2011 cited by 718

  22. Protocols for multi‐site trials using hyperpolarized 129Xe MRI for imaging of ventilation, alveolar‐airspace size, and gas exchange: A position paper from the 129Xe MRI clinical trials consortium

    Authors: , , , , , , , , , , , , , , , , , , , , , - Magnetic Resonance in Medicine 2021 cited by 102

  23. The upper-airway microbiota and loss of asthma control among asthmatic children

    Authors: , , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 157

  24. Genetic analyses identify GSDMB associated with asthma severity, exacerbations, and antiviral pathways

    Authors: , , , , , , , , , , , , , , , , , , , - Journal of Allergy and Clinical Immunology 2020 cited by 93